Anti-ganglioside GD3 Therapeutic Antibody

1. mitumomab (TAB-764) DESCRIPTION CATALOG # SIZE Anti-ganglioside GD3 Therapeutic Antibody TAB-764 1mg PRODUCT INFORMATION Product Overview Recombinant mouse monoclonal antibody expressed in CHO binding to human ganglioside GD3. Mitumomab is a mouse monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Mitumomab attacks tumour cells, while the vaccine is thought to activate the immune system. Target ganglioside GD3 Type IgG2b - kappa Immunogen The details of the immunogen for this antibody are not available. Species Reactivity Human Expression Host CHO Applications Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods. CAS 216503-58-1 Molecular Weight 717.27994 Purity >95.0% as determined by analysis by RP-HPLC. Size                                          

2. 1mg Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.       BACKGROUND Introduction Mitumomab (BEC-2) is a mouse monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Antigen Description Gangliosides are membrane-bound glycosphingolipids containing sialic acid. Ganglioside GD3 is known to be important for cell adhesion and growth of cultured malignant cells. The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to GM3 to produce gangliosides GD3 and GT3. The encoded protein may be found in the Golgi apparatus and is a member of glycosyltransferase family 29. Function alpha-N-acetylneuraminate alpha-2, 8-sialyltransferase activity; sialyltransferase activity; transferase activity, transferring glycosyl groups; Gene ID 6489 Synonyms ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2, 8-sialyltransferase 1; sialyltransferase 8 (alpha N acetylneuraminate: alpha 2, 8 sialytransferase, GD3 synthase) A , SIAT8, SIAT8A; alpha-N-acetylneuraminide alpha-2, 8-sialyltransferase; ST8Sia I; ganglioside GD3 synthase; ganglioside GT3 synthase; sialytransferase St8Sia I; alpha-2, 8-sialyltransferase 8A; disialoganglioside (GD3) synthase; ganglioside-specific alpha-2, 8-polysialyltransferase; sialyltransferase 8 (alpha-N-acetylneuraminate: alpha-2, 8-sialytransferase, GD3 synthase) A; sialyltransferase 8A (alpha-N-acetylneuraminate: alpha-2, 8-sialyltransferase, GD3 synthase); GD3S; SIAT8; SIAT8A; SIAT8-A; ST8SiaI;                     Related Products TAB-877 Anti-Human Tenascin C/TNC Therapeutic Antibody    

3. TAB-241 Anti-Human ICAM-1 Therapeutic Antibody Fab fragment TAB-036-F(E) Anti-Human Fibrin II, beta chain therapeutic Antibody Fab Fragment (FibriScint) TAB-711 Anti-MS4A1 Therapeutic Antibody (VERLUMA) TAB-768 Anti-TNF alpha Therapeutic Antibody TAB-H32 Anti-Human CD15 Therapeutic Antibody TAB-014-F(E) Anti-Human CEA therapeutic Antibody Fab Fragment (CEA-Scan) TAB-737 Anti-B cell lymphomas Therapeutic Antibody TAB-H26 Anti-Human IL6 Therapeutic Antibody TAB-047-F(E) Anti-Human CD22 Therapeutic Antibody Fab Fragment(LymphoScan)                                    